Home LiteratureArticle Details
PMID: 25852552 Published · epublish English Journal Article Review

Peptide ligand recognition by G protein-coupled receptors.

Frontiers in pharmacology ·Vol. 6 ·2015-00-00 ·Pages 48

Krumm BE, Grisshammer R

Abstract

The past few years have seen spectacular progress in the structure determination of G protein-coupled receptors (GPCRs). We now have structural representatives from classes A, B, C, and F. Within the rhodopsin-like class A, most structures belong to the α group, whereas fewer GPCR structures are available from the β, γ, and δ groups, which include peptide GPCRs such as the receptors for neurotensin (β group), opioids, chemokines (γ group), and protease-activated receptors (δ group). Structural information on peptide GPCRs is restricted to complexes with non-peptidic drug-like antagonists with the exception of the chemokine receptor CXCR4 that has been crystallized in the presence of a cyclic peptide antagonist. Notably, the neurotensin receptor 1 is to date the only peptide GPCR whose structure has been solved in the presence of a peptide agonist. Although limited in number, the current peptide GPCR structures reveal great diversity in shape and electrostatic properties of the ligand binding pockets, features that play key roles in the discrimination of ligands. Here, we review these aspects of peptide GPCRs in view of possible models for peptide agonist binding.

Keywords
GPCR structure chemokine receptors neurotensin receptor opioid receptors peptide GPCRs peptide agonist protease activated receptors
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Krumm Brian E
Membrane Protein Structure Function Unit, National Institute of Neurological Disorders and Stroke - National Institutes of Health Rockville, MD, USA.
Grisshammer Reinhard
Membrane Protein Structure Function Unit, National Institute of Neurological Disorders and Stroke - National Institutes of Health Rockville, MD, USA.
References (36)
36 references, click to expand
  1. Targeting neurotensin receptors with agonists and antagonists for therapeutic purposes.
    Curr Opin Drug Discov Devel. 2002 Sep;5(5):764-76 PMID: 12630297
  2. Crystal structure of the β2 adrenergic receptor-Gs protein complex.
    Nature. 2011 Jul 19;477(7366):549-55 PMID: 21772288
  3. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant.
    Nature. 2015 Mar 12;519(7542):247-50 PMID: 25533960
  4. Opioids and their receptors: Are we there yet?
    Neuropharmacology. 2014 Jan;76 Pt B:198-203 PMID: 23624289
  5. Crystal structure of the ligand-free G-protein-coupled receptor opsin.
    Nature. 2008 Jul 10;454(7201):183-7 PMID: 18563085
  6. High-resolution crystal structure of human protease-activated receptor 1.
    Nature. 2012 Dec 20;492(7429):387-92 PMID: 23222541
  7. Specificity of the thrombin receptor for agonist peptide is defined by its extracellular surface.
    Nature. 1994 Apr 14;368(6472):648-51 PMID: 8145852
  8. Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.
    Nature. 2012 Mar 21;485(7398):321-6 PMID: 22437502
  9. Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic.
    Nature. 2012 May 16;485(7398):395-9 PMID: 22596163
  10. Crystal structure of metarhodopsin II.
    Nature. 2011 Mar 31;471(7340):651-5 PMID: 21389988
  11. Inverse, protean, and ligand-selective agonism: matters of receptor conformation.
    FASEB J. 2001 Mar;15(3):598-611 PMID: 11259378
  12. The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.
    J Biol Chem. 1973 Oct 10;248(19):6854-61 PMID: 4745447
  13. The structural basis for agonist and partial agonist action on a β(1)-adrenergic receptor.
    Nature. 2011 Jan 13;469(7329):241-4 PMID: 21228877
  14. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.
    Science. 2007 Nov 23;318(5854):1258-65 PMID: 17962520
  15. Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.
    Science. 2010 Nov 19;330(6007):1066-71 PMID: 20929726
  16. Structure and function of an irreversible agonist-β(2) adrenoceptor complex.
    Nature. 2011 Jan 13;469(7329):236-40 PMID: 21228876
  17. Structure of the δ-opioid receptor bound to naltrindole.
    Nature. 2012 May 16;485(7398):400-4 PMID: 22596164
  18. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
    Annu Rev Immunol. 1999;17:657-700 PMID: 10358771
  19. Structure-function of the G protein-coupled receptor superfamily.
    Annu Rev Pharmacol Toxicol. 2013;53:531-56 PMID: 23140243
  20. Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.
    Science. 2015 Mar 6;347(6226):1117-22 PMID: 25612609
  21. Thrombin signalling and protease-activated receptors.
    Nature. 2000 Sep 14;407(6801):258-64 PMID: 11001069
  22. DAMGO recognizes four residues in the third extracellular loop to discriminate between mu- and kappa-opioid receptors.
    Eur J Pharmacol. 1998 Jun 5;350(2-3):301-10 PMID: 9696421
  23. Thrombin receptor activating mutations. Alteration of an extracellular agonist recognition domain causes constitutive signaling.
    J Biol Chem. 1996 Jan 12;271(2):702-6 PMID: 8557676
  24. Structure of an agonist-bound human A2A adenosine receptor.
    Science. 2011 Apr 15;332(6027):322-7 PMID: 21393508
  25. Beta-arrestin-biased ligands at seven-transmembrane receptors.
    Trends Pharmacol Sci. 2007 Aug;28(8):416-22 PMID: 17644195
  26. Molecular control of δ-opioid receptor signalling.
    Nature. 2014 Feb 13;506(7487):191-6 PMID: 24413399
  27. Structure of signaling-competent neurotensin receptor 1 obtained by directed evolution in Escherichia coli.
    Proc Natl Acad Sci U S A. 2014 Feb 11;111(6):E655-62 PMID: 24453215
  28. Structure of the agonist-bound neurotensin receptor.
    Nature. 2012 Oct 25;490(7421):508-13 PMID: 23051748
  29. Peptides as receptor selectivity modulators of opiate pharmacophores.
    J Med Chem. 1986 Jul;29(7):1222-5 PMID: 2879914
  30. Chemokines and leukocyte traffic.
    Nature. 1998 Apr 9;392(6676):565-8 PMID: 9560152
  31. Crystal structure of a lipid G protein-coupled receptor.
    Science. 2012 Feb 17;335(6070):851-5 PMID: 22344443
  32. Structure of the CCR5 chemokine receptor-HIV entry inhibitor maraviroc complex.
    Science. 2013 Sep 20;341(6152):1387-90 PMID: 24030490
  33. Structure of a nanobody-stabilized active state of the β(2) adrenoceptor.
    Nature. 2011 Jan 13;469(7329):175-80 PMID: 21228869
  34. G protein-coupled receptors. I. Diversity of receptor-ligand interactions.
    J Biol Chem. 1998 Jul 10;273(28):17299-302 PMID: 9651309
  35. The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex.
    Proc Natl Acad Sci U S A. 2009 Jun 9;106(23 ):9501-6 PMID: 19470481
  36. Structure of the human κ-opioid receptor in complex with JDTic.
    Nature. 2012 Mar 21;485(7398):327-32 PMID: 22437504
Article Info
Journal
Frontiers in pharmacology
Abbr.
Front Pharmacol
ISSN
1663-9812
Published
2015-00-00
Epub
2015-00-16
Pages
48
Language
English
Region
Switzerland
NLM ID
101548923
PMCID
PMC4360564
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com